Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for L-dopa Induced Dyskinesias
NCT00076674Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in levodopa-induced dyskinesia (LID) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Validated motor function scales at 6 weeks. Started Jan 2004; status: completed.
02
Drugs
levetiracetam
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT00076674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076674.